Effect of bazedoxifene either alone or in combination with an aromatase inhibitor or conjugated estogene (CE) in the prevention of mammary cancers.
Ended Awarded Last action
- Contract number
- HHSN26100007
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $544,547
Award facts
- Contract value 100% obligated
- $544,546.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$558 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $545,105 |
Quick answers
Who was awarded contract HHSN26100007?
HHSN26100007 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 12, 2014.
How much is contract HHSN26100007 worth?
The government has obligated $544,547 on HHSN26100007.
Is contract HHSN26100007 an order under another contract?
Yes. HHSN26100007 is a delivery order under HHSN261201200021I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100007 competed?
The extent of competition for HHSN26100007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award